KENILWORTH (NJ) (dpa-AFX) - French drug maker Sanofi (SNY) and Merck & Co. (MRK), known as MSD outside the U.S. and Canada, announced Tuesday the availability of Vaxelis, the first and only hexavalent
Sanofi, Merck launch six-in-one pediatric combo vaccine June 1, 2021
8:16 am
A six-in-one pediatric combination vaccine including diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus B conjugate and hepatitis B launched in the United States on June 1 after being developed by Sanofi and Merck.
Vaxelis is given to children from 6 weeks through 4 years of age, up until their fifth birthday, and is given as three shots: one at 2 months, one at 4 months and one at 6 months of age.
“As the first six-in-one vaccine in the U.S., Vaxelis is now available to help protect infants and children against diseases caused by six infectious agents. We are proud to offer this vaccine to health care professionals and the patients they serve,” said Elaine O’Hara, head of Sanofi Pasteur Commercial Operations North America, in a prepared statement. “Studies have shown that combination vaccines may help reduce the shot burden and improve coverage rates
February 28, 2021, Dr. Sucharit Bhakdi, a retired professor, microbiologist and infectious disease and immunology specialist, along with several other doctors and scientists who have formed Doctors for COVID Ethics, sent a letter1 to the European Medicines Agency (EMA), warning about the potential for gene-based COVID-19 “vaccines” to cause blood clots, cerebral vein thrombosis and sudden death. The signees listed several questions in need of urgent answers, including evidence that gene-based vaccines will not enter the bloodstream and disseminate throughout the body, or that the vaccines will not remain entrapped in circulation and taken up by endothelial cells. They warned that, … Continue reading →
Sen Cabrera Votes For The Passage Of Comprehensive Bill patch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from patch.com Daily Mail and Mail on Sunday newspapers.
Cherokee Nation now offering COVID-19 vaccinations for ages 12-15
The tribe’s health centers in Tahlequah, Vinita, Muskogee and Sallisaw will offer the vaccine to this age group every weekday. Author: 5NEWS Web Staff Updated: 12:34 PM CDT May 20, 2021
TAHLEQUAH, Okla. The Cherokee Nation is now offering the Pfizer COVID-19 vaccine to children ages 12-15 at all health center locations.
The Centers for Disease Control & Prevention Advisory Committee on Immunization Practices recently approved a revised and expanded FDA Emergency Use Authorization for the Pfizer vaccine to allow immunization of ages 12 and older.
Cherokee Nation s Tahlequah, Vinita, Muskogee and Sallisaw health centers will offer the vaccine to this age group Monday through Friday, and its other health centers will offer it on Tuesday, Wednesday and Thursday each week.